Skip to main content

Table 1 Characteristics of the experimental groups at sacrifice (12 weeks).

From: Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure

   Sham
N = 8
MI
N = 10
MI-VI
N = 9
MI-VL
N = 9
A BW (g)
(baseline)
321 ± 9 313 ± 5 321 ± 2 306 ± 4
  BW (g)
(12 week)
446 ± 15 449 ± 11 436 ± 5 450 ± 7
  LVW (g)
(12 week)
0.93 ± 0.03 1.05 ± 0.03* 0.97 ± 0.02 1.08 ± 0.03*
  LVW/BW 2.00 ± 0.05 2.34 ± 0.09** 2.22 ± 0.05 2.39 ± 0.05**
B Glucose (mmol/L)
(3 week)
9.0 ± 0.6 8.0 ± 0.5 7.8 ± 0.3 9.5 ± 0.4
  Glucose (mmol/L)
(6 week)
7.2 ± 0.2 7.3 ± 0.3 7.1 ± 0.1 7.7 ± 0.2
  Glucose (mmol/L)
(12 week)
8.0 ± 0.3 7.3 ± 0.2 8.0 ± 0.3 7.6 ± 0.2
  Cholesterol (mmol/L) 1.49 ± 0.09 1.48 ± 0.04 1.45 ± 0.08 1.39 ± 0.07
  Triglycerides (mmol/L) 0.95 ± 0.19 1.12 ± 0.13 0.84 ± 0.11 0.86 ± 0.12
  1. Data are presented as means ± SEM; N indicates number of animals; BW, body weight; LVW, left ventricle weight; LVW/BW, left ventricle weight/body weight ratio.**P < 0.01 vs. Sham.*P < 0.05 vs. Sham.